Possible Solutions to Depression Using BCI Methods
DOI:
https://doi.org/10.54097/hset.v39i.6575Keywords:
Depression; Brain-Computer Interaction; Modified ECT.Abstract
According to the research results of 2022, the blue book of depression in China, there exists about 95,00,000 depression patients in China and the number is still growing. Depression is becoming an increasingly severe disease. As it is generally believed that the etiology of depression is multifaceted, related to gender differences, chronic stress, dietary behavior, and the abuse of drugs and alcohol. Clinical treatment is mainly on drugs, but BCI methods cannot be ignored. Compared to traditional methods, the BCI methods like Electroconvulsive therapy (ECT), repetitive Transcranial Magnetic Stimulation (rTMS) or Deep Brain Stimulation (DBS), DBS has many advantages, for patients whose physical conditions are not very ideal, the side effect of drugs may lead to serious conditions. in this paper is mainly focused on the use of BCI including technical background, applicable crowd, taboos and sequels. In the end of the passage some data from clinical cases would be discussed to give a specific impression about the methods. Then a possible scheme would be apposed about a possible solution to avoid triggering the side-effect of ECT in clinical conditions.
Downloads
References
Malhi G S, Mann J J. Depression [J]. The Lancet, 2018, 392(10161): 2299-2312.
Friedrich M J. Depression is the leading cause of disability around the world [J]. JAMA, 2017, 317(15): 1517-1517.
Li Junfeng et al. Anxiety and depression among general population in China at the peak of the COVID-19 epidemic [J]. World Psychiatry, 2020, 19(2): 249-250.
Li Kaimin ,Wu Yan ,Li Kefeng Be Prepared for a Mental Illness "Pandemic" in China: Too Early to Celebrate the Victory Over COVID-19[J].Disaster Medicine and Public Health Preparedness, 2021: 1-2.
Vos T, Lim S S, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. The Lancet, 2020, 396(10258): 1204-1222.
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. The Lancet Psychiatry, 2022, 9(2): 137-150.
Kessler R C, Akiskal H S, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers [J]. American Journal of Psychiatry, 2006, 163(9): 1561-1568.
CUIJPERS P, VOGELZANGS N, TWISK J, et al. Comprehensive Meta-Analysis of Excess Mortality in Depression in the General Community Versus Patients With Specific Illnesses [J]. American Journal of Psychiatry, 2014, 171(4): 453-462.
Walker E R, Mcgee R E, Druss B G. Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis [J]. Jama Psychiatry, 2015, 72(4): 334-341.
Insel T R, Ssolnick E M. Cure therapeutics and strategic prevention: raising the bar for mental health research [J]. Molecular Psychiatry, 2006, 11(1): 11-17.
Shadrina M, Bondarenko E A, Slominsky P A. Genetics Factors in Major Depression Disease [J]. Frontiers in Psychiatry, 2018, 9.
Kendler K S, Halberstadt L J. The road not taken: life experiences in mono zygotic twin pairs discordant for major depression [J]. Molecular Psychiatry, 2013, 18(9): 975-984.
Villanueva R. Neurobiology of Major Depressive Disorder [J]. Neural Plasticity, 2013, 2013.
Kenneson A, Funderbukk J, Maisto S. Substance use disorders increase the odds of subsequent mood disorders [J]. Bipolar Disorders, 2013, 15: 150-150.
Filatova E V, Shadrina M I, Slominsky P A. Major Depression: One Brain, One Disease, One Set of Intertwined Processes [J]. Cells, 2021, 10(6).
Moffitt T E, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment [J]. Psychological Medicine, 2010, 40(6): 899-909.
Ustun T B, Kessler R C. Global burden of depressive disorders: the issue of duration [J]. The British journal of psychiatry: the journal of mental science, 2002, 181: 181-183.
Karrouri R, Hammani Z, Benjelloun R, et al. Major depressive disorder: Validated treatments and future challenges [J]. World J Clin Cases, 2021, 9(31): 9350-9367.
Gartlehner G, Wagner G, Matyas N, et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews [J]. Bmj Open, 2017, 7(6).
Mccarron R M, Shapiro B, Rawles J, et al. Depression [J]. Annals of Internal Medicine, 2021, 174(5): ITC65-ITC80.
Katz M M, Tekell J L, Bowden C L, et al. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression [J]. Neuropsychopharmacology, 2004, 29(3): 566-579.
Little A. Treatment-Resistant Depression [J]. American Family Physician, 2009, 80(2): 167-172.
Grzinger M, Smith E S, Conca A. On the significance of elektroconvulsive therapy in the treatment of severe mental diseases[J]. Wiener klinische Wochenschrift, 2015, 127(7):297-302.
Nice puts curb on use of ECT. Ment Health Today 2003;6.
V. Uppal, J. Dourish, A. Macfarlane Anesthesia for electroconvulsive therapy Br J Anesth, 10 (6) (2010), pp. 192-196.
Lupke K, Warren N, Teodorczuk A, Steele S, Kolur U, Wand A, Robinson G, Parker S. A systematic review of modified electroconvulsive therapy (ECT) to treat delirium. Acta Psychiatr Scand. 2022 Aug 22. doi: 10.1111/acps.13492. Epub ahead of print. PMID: 35996219.
Susan L, Charlene L, James B. The Historical Struggles of Modified Electroconvulsive Therapy: How Anesthesia Came to the Rescue, Journal of Anesthesia History, Volume 7, Issue 2,2021, Pages 17-25, ISSN 2352-4529.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







